A methodologic study was performed to compare the polymerase chain reaction (PCR) and Southern blot hybridization, two commonly used testing strategies for the detection of human papillomavirus (HPV) infection. Three laboratories tested masked aliquots of exfoliated cervical cell specimens obtained from 120 women by cervicovaginal lavage. The study population included 32 women with condylomatous atypia or cervical intraepithelial neoplasia and 88 control women with no known history of cervical neoplasia. Two laboratories used PCR with different sets of consensus primers for HPV detection. The third laboratory used low-stringency Southern blot hybridization to identify all HPV types, followed by high-stringency Southern and/or dot blot hybridization to confirm specific HPV types. One of the PCR primer sets detected HPV types with a differential efficiency that was not predicted by analysis of DNA sequences or direct testing of HPV-containing plasmids. In contrast, the second PCR primer set was shown to be a much broader consensus system, detecting the same HPV types as Southern blotting, though requiring much less clinical specimen. Over 80% of women with cervical intraepithelial neoplasia or condylomatous atypia were found to be HPV infected both by Southern blotting and by the second PCR primer set. Among the control women, 11% were HPV positive by Southern blotting, while 31% were positive with the second set of primers. Most of the HPV infections found only by PCR were not due to HPV type 6, 11, 16, 18, 31, 33, or 45. These known HPV types were uncommon among normal women in the study population, even as determined by the PCR method.
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The association of human papillomavirus (HPV) infection with cervical neoplasia has been firmly established by laboratory and epidemiologic investigations. The growing evidence suggesting that HPV infection is a causal factor in the development of cervical neoplasia provides an impetus to adapt HPV testing for gynecologic screening. Before HPV testing can be considered for routine use, the assays must be well validated, and accurate estimates of type-specific HPV prevalence among the various clinic populations targeted for screening must be obtained. Assay validation and HPV prevalence estimation will require, in turn, careful comparisons of available HPV testing methods.
Several HPV testing strategies have been employed over the past few years (4) . In particular, much attention has focused on the potential utility of polymerase chain reaction (PCR) methods to amplify HPV-specific DNA sequences (6) . PCR promises to be much more sensitive than previously used methods of HPV DNA detection. Moreover, PCR consensus primer sets, which hybridize to highly conserved regions of the HPV genome, have been designed to detect many known HPV types in a single amplification procedure. However, some early reports have suggested that PCR might detect HPV in the majority of women, thereby limiting the predictive value of a positive test (2, 9, 10). Because of the extreme sensitivity of PCR methods, there is some related concern that contamination or carry-over during large-scale specimen collection and processing could make PCR impractical for routine, widespread clinical use.
The methodologic comparison presented here was designed to evaluate two different sets of PCR consensus primers for the detection of genital HPV DNA. In planning this comparison, Southern blot DNA-DNA hybridization was considered to be the current "gold standard" assay because of its well-defined sensitivity and because of the type specificity provided by combined hybridization and restriction enzyme analysis. Each of the three assay methods was performed in a separate laboratory with masked aliquots of the same 120 cervical cell samples. The control women had a median age of 30 years, and, like the case women, most were white (89%) and parous (56%). Unlike the case women, most (60%) of the control women were married, and they also tended to be better educated and wealthier than the case women. Because of oversampling, more of the control women were pregnant (22% [all firsttrimester pregnancies]) and more were using oral contraceptives (26%) than in the Portland disease-free cohort from which the control group was chosen (7% first-trimester pregnancies and 19% using oral contraceptives).
MATERIALS AND METHODS
The cervical cell samples used for HPV testing were obtained as follows. For each woman, a 10-ml saline lavage of the cervix was performed, and the sample obtained was transported to the processing laboratory on wet ice. One milliliter of the lavage specimen was withdrawn and frozen. The remaining 9 ml was centrifuged to produce a dry cell pellet, which was resuspended in saline and divided to form two dry cell pellets, each derived from 4.5 ml of lavage specimen. Southern blot analyses were performed with one of the cell pellets, and the first PCR consensus primer set (PCR 1) was applied to the other identical pellet. Subsequently, to evaluate a second PCR consensus primer set (PCR 2), the reserve 1-ml lavage specimen was used. The PCR methods each used such small fractions of the specimens that the difference in DNA content between the different aliquots (cell pellet versus lavage) was thought not to be an important variable. PCR amplification methods. As shown in Results, PCR 1 amplified different HPV types with differential efficiency; thus, this system was abandoned. In the presentation of methods, therefore, the methodologic details of PCR 2 will be emphasized. The Table 2 . By all three methods, samples from women with condylomatous atypia or CIN were significantly more likely to be positive than samples from women with normal cytologic diagnoses or reactive atypia (P < 0.01 for all three methods). This case-control difference could not be explained by taking into account any of the demographic differences between the two groups. 
Negative strand JCB2 (21-mer) 5'TGAAAAAYAAA CTGTARAT CA HPV 6b
------T---T---A----
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Negative strand MY09 (20-mer)
5'CGTCCMARRGGAWACTGATC HPV 6b ----C-AA---T------7171 HPV 11 ----A-GG---A------7155 HPV 16 ----T-AA---A------7035 HPV 18 ----A-GG---T-T----7012 HPV 31 --A-C-GT---A------6951 HPV 33 ----C-AA---A------6988
Degenerate PCR 2 found more samples positive than Southern blotting, while PCR 1 found the fewest samples positive. The larger number of samples that were HPV positive by PCR 2 compared with Southern blot hybridization was most evident among control women, because both methods detected HPV in the majority of women with condylomatous atypia or CIN. (One of the four samples from women with CIN 2/3 was judged inadequate for Southern blotting but, for this comparison, was grouped as HPV negative.) In contrast, PCR 1 detected fewer HPV infections in women with or without cytologic abnormalities than either of the other two methods. Table 3 highlights the difference in HPV detection between PCR 1 and Southern blotting. All samples considered Table 5 ). Agreement in HPV typing was good for those 36 samples considered positive by both methods. In the subset of 24 samples found by both Southern blotting and PCR 2 to contain a single HPV type, there was only one definite typing disagreement (taking into account the different sets of type-specific probes available in the two laboratories). Among the 12 samples found by at least one method to contain multiple HPV types, the two techniques tended to agree on at least one of the types present but to disagree on the total number of types (data not shown).
The 20 additional positive samples detected by PCR 2 alone were confirmed by repeat testing. As shown in Table 6 , only 4 (20%) of the 20 samples contained HPV type 6/11, 16, 18, 31, 33, or 45. Most of the additional positives were HPV types for which type-specific oligonucleotides were not available. As mentioned above with reference to Table 2 , these unidentified types were almost all from women with normal cytologic diagnoses or reactive atypia.
HPV types commonly associated with high-grade cervical neoplasia (types 16, 18, 31, and 33, in particular) were uncommon among the 87 control women, according to the results of either Southern blotting (prevalence, 1%) or PCR 2 (prevalence, 3%). Among the 32 case women with condylomatous atypia or CIN, these types were found in 44% by Southern blot and in 50% by PCR 2.
DISCUSSION
The results of this intermethod comparison demonstrate clearly that PCR primer performance cannot be predicted adequately by sequence homology or plasmid DNA experiments. PCR 1 appeared, by such preliminary criteria, to employ a consensus primer set capable of amplifying many known HPV types. In practice, however, the primer set amplified selected HPV types only. The reasons for this selective performance are unknown but may include the high AT nucleotide content of the primers. We conclude that optimization with clinical specimens is required before a primer set can be termed consensus, i.e., capable of detecting a broad range of HPV types. The cervicovaginal lavage used in this study to collect cervical cell specimens provides ample DNA, permitting optimal sensitivity of the Southern blot method (8) . The additional sensitivity of PCR might be more apparent in studies relying on less ample cervical scrapes or swabs because the PCR method required a specimen less than 1/100 the size of the clinical specimen used by Southern blot to obtain comparable results.
A remaining question is the clinical significance of the HPV infections of unidentified type found by PCR 2 alone. The HPV-positive women with such infections had mainly normal diagnoses or had reactive atypia. Some of the types considered unidentified by PCR 2 could be known or notyet-typed genital HPVs for which oligonucleotide probes were not available, and, alternatively, some of the apparent infections could be false-positive results. Further hybridization analyses with new probes, as well as cloning and sequencing efforts under way, should clarify this issue.
When either Southern blotting or PCR 2 was used, HPV types commonly associated with high-grade cervical neoplasia (types 16, 18, 31, and 33, in particular) were found in less than 10% of our control population but in nearly 50% of the case population. The low prevalence of these particular HPV types among cytologically normal women in our study group suggests that type-specific HPV screening might serve as a useful predictor of undetected or incipient cervical neoplasia in this population. An ongoing cohort study of the same Kaiser Permanente patient population is designed to investigate the utility of such screening. In this context, it is important to note that the control women in our study can be considered a population at low risk for HPV infection. Their median age was 30, most were married, and we excluded by chart review all women with a medical history of cervical neoplasia. From other studies, it appears that HPV prevalence peaks in women with multiple sexual partners in their early to mid-twenties and then declines with increasing age (3) . Thus, studies of younger, unmarried female populations (1) might be expected to yield higher HPV prevalences among cytologically normal women than we observed, and the predictive value of a positive HPV test would decline as a result.
In conclusion, we have shown that a carefully optimized PCR method compares favorably with Southern blot hybridization and shows promise for HPV DNA detection in clinical specimens. As sensitive PCR assays are compared and validated, it will be important to reach a scientific consensus regarding two important issues that remain controversial: the prevalence of different types of HPV in women with normal and abnormal cytologic diagnoses and the corresponding prognostic importance of HPV DNA detection.
